Introduction: Asparagus aphyllus L.,Crataegus azarolus L., and Ephedra alata Decne.have been used in traditional Greco-Arab herbal medicine to treat various metabolic and inflammatory diseases. However, to our knowledge, no scientific evidences regarding their anti-inflammatory effects have been published yet.This study aimedto evaluate the antioxidant and anti-inflammatory properties of Asparagus aphyllus L., Crataegus azarolus L., and Ephedra alata Decne.extracts using in vitro mono and co-culture systems. Methods: In the first phase of the current study we measured the total phenol, flavones and flavonol contents as well as the antioxidant activity using the DPPH scavenging assay, ABTS assay, and reducing power of the three plant extracts. In second phase, we used THP-1-derived macrophages as a monoculture and co-culture with hepatic cell line (HepG2) to assess the effects of the three plant extracts on the production of LPSinduced pro-inflammatory (IL-6 and TNF -) and anti-inflammatory (IL-10) cytokines.Results: All three extracts exhibit relatively high levels of phenolics, flavones and flavonols, which correlate with their antioxidant capacities.All three extracts were found to modulate the secretion levels of TNF -, IL-6 and IL-10 at non-toxic concentrations as measured with MTT and LDH assays. Conclusion: Taken together, our results suggest that the traditional uses of these extracts as anti-inflammatory remedies may be mediated by their significant antioxidant capacity, inhibition of pro-inflammatory cytokines secretion concomitant with enhancement of anti-inflammatory cytokines secretion.Key words: Anti-inflammatory, Antioxidant; Asparagus aphyllus L.; Crataegus azarolus L.;Ephedra alata Decne.
INTRODUCTIONInflammation is the first response of the immune system to infection, irritation, as well as to various other diseases such as cancer, cardiovascular diseases, obesity, hypertension, diabetes, autoimmune, and neurodegenerative disorders.1 it involves directed migration and activation of leukocytes (neutrophils, monocytes and eosinophils) to the site of damage. Inflammation is linked to oxidant/antioxidant imbalance (an elevation in the reactive oxygen speciesin parallel to low levels of antioxidants). High levels of inflammatory markers and low level of antioxidants are observed in many inflammatory diseases 2,3 as well as in many pathological conditions such as malignancy, cardiovascular disease, diabetes type 2, kidney malfunction, gastrointestinal disorders, microbial infection, fibrogenesis, and neurological diseases. The imbalance between production of antioxidants versus getting rid of free radical species leads to oxidative stress. [4][5][6] Inflammation is driven by the release of a wide range of pro-inflammatory mediators, such as the pro-inflammatory cytokines IL-1β, IL-TNF-α, IL-6, IL 8, and IFN-γ. Anti-inflammatory cytokines that includes IL-1 receptor antagonist, IL-4, IL-6, IL-10, IL-11, and IL-13 down regulate the inflammatory response. Chemo-therapeutic anti-inflammatory dr...